TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/19 20:58 | 3/18/19 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allouche Cyril | CA | O | Principa | S | -8 | 15.48 | 0 | 0 | -7 | 6 | D | ||||||||||||||
1/23/19 21:38 | 1/22/19 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allouche Cyril | CA | O | Principa | S.d | -11 | 17.77 | 0 | -1 | -14 | 4 | D | ||||||||||||||
1/4/19 21:33 | 1/3/19 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allouche Cyril | CA | O | Principa | S | -7 | 19.48 | 0 | 0 | -9 | 4 | D | ||||||||||||||
11/21/18 18:30 | 11/20/18 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allouche Cyril | CA | O | Principa | S | -10 | 20.66 | 0 | 0 | -11 | 4 | D | ||||||||||||||
11/9/18 20:59 | 11/9/18 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allouche Cyril | CA | O | Principa | S.d | -52 | 23.72 | 0 | -2 | -32 | 5 | D | ||||||||||||||
7/6/18 21:17 | 7/6/18 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allouche Cyril | CA | O | Principa | S | -11 | 28.35 | 0 | 0 | -8 | 5 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |